Auctus Biologics
Lafayette
About Auctus Biologics
Auctus Biologics is a pre-clinical biotechnology company that develops antibody mimetics for therapeutic and diagnostic applications.Antibodies are the most prolific biologics in clinical environments because of their ability to bind targets with high affinity and specificity. However, antibodies also carry liabilities. They are often unstable and require costly cold-chain management to reach their destinations in active form. Because of their fragility, antibodies typically cannot be used in extreme environments like the gastrointestinal tract and can require lengthy infusions to administer to patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.7M
- Funding stage: Seed
- Last round: Grant (Feb 2022)
- Website: auctusbiologics.com
Industries & Categories
Biotechnology, Medical
Canonical: https://fsome.com/organization/auctus-biologics-81458 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.